1. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality
    Aaron P. Thrift et al, 2019, Clinical Gastroenterology and Hepatology CrossRef
  2. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
    Sae Hwan Lee et al, 2015, BMC Cancer CrossRef
  3. Proanthocyanidins extracted from grape seeds inhibit the growth of hepatocellular carcinoma cells and induce apoptosis through the MAPK/AKT pathway
    Wancai Zheng et al, 2022, Food Bioscience CrossRef
  4. Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
    Hideko Ohama et al, 2023, Oncology CrossRef
  5. Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting β-catenin
    Li-Yan Wang et al, 2015, Asian Pacific Journal of Tropical Medicine CrossRef
  6. Polypyridyl Ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer
    Yumei Li et al, 2019, European Journal of Medicinal Chemistry CrossRef
  7. Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report
    XIANLI CHEN et al, 2015, Oncology Letters CrossRef
  8. OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
    Hany A. Omar et al, 2016, Frontiers in Pharmacology CrossRef
  9. CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
    Masatoshi Kudo et al, 2021, Journal of Hepatology CrossRef
  10. Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States
    Helen M. Parsons et al, 2017, Liver Cancer CrossRef
  11. Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma
    Rui Zhao et al, 2018, Oncology Letters CrossRef
  12. Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
    Jasmine Huynh et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  13. Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
    Francesco Tovoli et al, 2016, Hepatic Oncology CrossRef
  14. Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study
    Cassia Regina Guedes Leal et al, 2018, Investigational New Drugs CrossRef
  15. Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE
    Jan B. Hinrichs et al, 2016, European Radiology CrossRef
  16. Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma
    Bohyun Kim et al, 2021, European Radiology CrossRef
  17. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
    Mingsheng Huang et al, 2016, European Radiology CrossRef
  18. Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
    Xiuqi Wu et al, 2019, Molecular Therapy CrossRef
  19. Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
    Tiago de Castro et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  20. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
    Xue-Fen Lei et al, 2018, World Journal of Clinical Cases CrossRef
  21. The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development
    D. J. Pinato et al, 2017, Alimentary Pharmacology & Therapeutics CrossRef